Novo Nordisk Raises 2026 Outlook as Obesity Sales Climb 22% in Q3
Novo Nordisk reported third-quarter net profit of 16.74 billion Danish kroner, down 16% year over year, and EPS of 3.79 kroner, also down 16%. Adjusted net profit fell 12% to 25.60 billion kroner.
Story updates
07:47:50 AM UTC
SquawkNews
BUZZ-Novo Nordisk seen rising as Wegovy pill, Q3 profit beat forecasts ** Shares in Novo Nordisk NOV
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Novo Nordisk A/S (NVO, NOVOB.CO, NOV.DE) reported third quarter net profit of 16.74 billion Danish kroner, a decline of 16% year-over-year. Earnings per share/ ADR was 3.79 kroner, down 16%. Adjusted net profit was 25.60 billion kroner, down 12% from last year…